CEO of Genelabs Resigns

February 12, 2008
BioPharm International Editors

James A.D. Smith, president, chief executive officer, and director of Genelabs Technologies, Inc. (Redwood City, CA) has resigned.

James A.D. Smith, president, chief executive officer, and director of Genelabs Technologies, Inc. (Redwood City, CA) has resigned. Until a successor is appointed, Irene A. Chow, executive chair of Genelabs’ board of directors, and Frederick W. Driscoll, CFO, will assume leadership responsibilities.

Genelabs announcement

Related Content:

News